Why we aren’t winning against TB: the most common diagnostics for tuberculosis are not diagnostics
Nearly one-third of the global population has Tuberculosis (TB) infection. Each year, 10 million people get active TB disease and 1.4 million die. But despite being one of the first ever human illnesses to be discovered and described over a thousand years ago, there remains a need for effective diagnostics, treatments, and vaccines for TB.
In this presentation, Dr Titus Divala will describe his TB research from a clinical epidemiology and diagnostics perspective, with a focus on a very common but poorly described overlap between TB and antimicrobial resistance: not TB drugs but for commonly used antibiotics.
Dr Divala will talk through two systematic reviews and a randomised controlled trial all focused on TB in the primary care setting and implications on patients, local health systems and global health actors.